Clinical Trials Using Autologous Tumor Cell Vaccine

Clinical trials are research studies that involve people. The clinical trials on this list are studying Autologous Tumor Cell Vaccine. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Personalized DNA Vaccine in Treating Patients with Triple-Negative Breast Cancer following Chemotherapy

    This phase I trial studies the side effects of a personalized deoxyribonucleic acid (DNA) vaccine in treating patients with triple-negative breast cancer following chemotherapy. The personalized DNA vaccine is designed to target mutations specific to each person's tumor that are discovered during genetic testing. Vaccines made from a person's DNA may help the body build a better immune response to kill tumor cells.
    Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri